Fortress Biotech, Inc. FBIO
2.04 USD +0.10 (+5.15%)
Nov 4, 2026, 10:02 AM EST
1.98 Day range 2.04
1.83 52-week range 4.53
- YTD
- -44.26%
- 1 year
- -17.41%
Analyst view
Price target (mean) 14.33 +602.6% upside
Now 2.04
- Target (low)
- 4.00
- Target (mean)
- 14.33
- Target (high)
- 24.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.75 | -0.75 – -0.75 | 0.00 | 0.0% | 15.58M | -24.4% | 1 |
| Current year | -3.28 | -3.28 – -3.28 | 0.00 | 0.0% | 58.13M | -31.2% | 1 |
| Next year | -0.87 | -0.87 – -0.87 | -3.28 | +73.5% | 136.43M | +134.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| May 16, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Mar 19, 2024 | Alliance Global Partners | Initiated | — | Buy |
| Nov 29, 2023 | Roth MKM | Maintained | Buy | Buy |